Alzheimer’s Drug Responsible For Half of Medicare B Premium Hike

Published on November 13, 2021

Health officials said Friday that a new Alzheimer’s drug is responsible for about half the reason why Medicare’s “Part B” outpatient premium will have one of the most significant increases ever in 2022, according to The Associated Press.The other half of the premium…

Read Full Article (External Site)